Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,020.00
-105.00 (-4.94%)
Dec 19, 2024, 3:19 PM KST

Kangstem Biotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
116,032133,971109,830124,057196,458169,714
Upgrade
Market Cap Growth
48.45%21.98%-11.47%-36.85%15.76%-62.62%
Upgrade
Enterprise Value
97,821129,76185,183115,828180,137145,899
Upgrade
Last Close Price
2070.002395.002514.772840.525613.975777.21
Upgrade
PS Ratio
8.7710.556.7410.0021.5028.26
Upgrade
PB Ratio
2.442.672.081.744.042.47
Upgrade
P/TBV Ratio
2.042.822.271.853.912.52
Upgrade
EV/Sales Ratio
7.6610.215.239.3419.7124.30
Upgrade
Debt / Equity Ratio
0.160.270.250.200.370.45
Upgrade
Asset Turnover
0.200.160.180.130.090.06
Upgrade
Inventory Turnover
14.7721.1618.5717.3726.055.88
Upgrade
Quick Ratio
2.232.072.733.383.182.36
Upgrade
Current Ratio
2.972.553.223.803.672.69
Upgrade
Return on Equity (ROE)
-26.14%-45.17%-32.55%-36.40%-33.65%-45.39%
Upgrade
Return on Assets (ROA)
-19.06%-17.59%-13.99%-15.31%-11.93%-15.49%
Upgrade
Return on Capital (ROIC)
-23.74%-21.93%-16.97%-18.68%-14.06%-17.58%
Upgrade
Earnings Yield
-7.39%-16.38%-18.42%-17.21%-9.40%-14.52%
Upgrade
FCF Yield
-13.84%-13.35%-17.82%-17.43%-8.67%-16.89%
Upgrade
Buyback Yield / Dilution
-42.69%-7.02%-36.23%-24.89%-6.99%-13.71%
Upgrade
Total Shareholder Return
-42.69%-7.02%-36.23%-24.89%-6.99%-13.71%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.